The PAH chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PAH chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The PAH stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View PAH Detailed Price Forecast - CNN Money||View PAH Detailed Summary - Google Finance|
|View PAH Detailed Summary - Yahoo! Finance||View PAH Stock Research & Analysis - Zacks.com|
|View PAH Trends & Analysis - Trade-Ideas||View PAH Major Holders - Barrons|
|View PAH Call Transcripts - NASDAQ||View PAH Breaking News & Analysis - Seeking Alpha|
|View PAH Annual Report - CompanySpotlight.com||View PAH OTC Short Report - OTCShortReport.com|
|View PAH Fundamentals - TradeKing||View PAH SEC Filings - Bar Chart|
|View Historical Prices for PAH - The WSJ||View Performance/Total Return for PAH - Morningstar|
|View the Analyst Estimates for PAH - MarketWatch||View the Earnings History for PAH - CNBC|
|View the PAH Earnings - StockMarketWatch||View PAH Buy or Sell Recommendations - MacroAxis|
|View the PAH Bullish Patterns - American Bulls||View PAH Short Pain Metrics - ShortPainBot.com|
|View PAH Stock Mentions - StockTwits||View PAH Stock Mentions - PennyStockTweets|
|View PAH Stock Mentions - Twitter||View PAH Investment Forum News - Investor Hub|
|View PAH Stock Mentions - Yahoo! Message Board||View PAH Stock Mentions - Seeking Alpha|
|View Insider Transactions for PAH - SECform4.com||View Insider Transactions for PAH - Insider Cow|
|View PAH Major Holdings Summary - CNBC||View Insider Disclosure for PAH - OTC Markets|
|View Insider Transactions for PAH - Yahoo! Finance||View Institutional Holdings for PAH - NASDAQ|
|View PAH Stock Insight & Charts - FinViz.com||View PAH Investment Charts - StockCharts.com|
|View PAH Stock Overview & Charts - BarChart||View PAH User Generated Charts - Trading View|
Global Agrochemicals Leader UPL Ltd. Names Leadership Teams as Arysta LifeScience Purchase Nears Completion
Posted on Thursday December 06, 2018
MUMBAI, INDIA, Dec. 06, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- UPL Limited today declared the new leadership appointments for the merged entity. On 20 July 2018, UPL, a global agrochemicals solutions provider, had announced that its wholly-owned subsidiary UPL Corp had signed a definitive agreement with Platform Specialty Products Corporation (PAH) to acquire Arysta LifeScience Inc. and its subsidiaries (collectively “Arysta”). The vision for New UPL is that it presents a huge opportunity to transform agriculture, enhance the lives of the farmers and grow the world's food supply sustainably.
Platform Specialty Announces New Term Loan B and Revolver
Posted on Wednesday November 21, 2018
Platform Specialty's (PAH) proposed facilities represent a strong step toward establishing a standalone Element Solutions.
Platform Specialty Products Corporation Announces Pricing and Preliminary Syndication of New Term Loan B and Revolver
Posted on Tuesday November 20, 2018
WEST PALM BEACH, Fla., Nov. 20, 2018 -- Platform Specialty Products Corporation (NYSE:PAH) ("Platform"), a global specialty chemicals company, announced today that it had.
Hedge Funds Keep Dumping Platform Specialty Products Corp (PAH); Bill Ackman Insists It’s Undervalued
Posted on Friday November 16, 2018
Insider Monkey has finished processing more than 700 13F filings made by hedge funds and prominent investors in Q3. These filings show these funds’ portfolio positions as of September 30. What do these smart investors think about Platform Specialty Products Corp (NYSE:PAH)? Hedge funds have been steadily losing conviction in the stock. Just 24 of […]